Primary |
Asthma |
53.3% |
Rheumatoid Arthritis |
13.3% |
Helminthic Infection |
6.7% |
Leukaemia |
6.7% |
Prophylaxis |
6.7% |
Rhinitis Allergic |
6.7% |
Sjogren's Syndrome |
6.7% |
|
Cushingoid |
14.3% |
Nausea |
14.3% |
Osteonecrosis |
14.3% |
Tremor |
14.3% |
Urticaria |
14.3% |
Weight Decreased |
14.3% |
White Blood Cell Count Increased |
14.3% |
|
Secondary |
Diffuse Large B-cell Lymphoma |
13.4% |
Acute Lymphocytic Leukaemia |
10.3% |
Non-hodgkin's Lymphoma |
10.3% |
Asthma |
8.2% |
Immunosuppressant Drug Therapy |
6.2% |
Prostate Cancer |
6.2% |
B-cell Lymphoma |
5.2% |
Diffuse Large B-cell Lymphoma Stage Iv |
5.2% |
Drug Use For Unknown Indication |
5.2% |
Chemotherapy |
3.1% |
Hypertension |
3.1% |
Juvenile Arthritis |
3.1% |
Polyarthritis |
3.1% |
Prophylaxis |
3.1% |
Pyrexia |
3.1% |
Rheumatoid Arthritis |
3.1% |
Bone Marrow Conditioning Regimen |
2.1% |
Crohn's Disease |
2.1% |
Heart Transplant |
2.1% |
Immunosuppression |
2.1% |
|
Urinary Tract Infection |
12.5% |
Neutropenia |
8.3% |
Weight Decreased |
8.3% |
Bronchopulmonary Aspergillosis |
4.2% |
Cardiomegaly |
4.2% |
Central Nervous System Lymphoma |
4.2% |
Cushingoid |
4.2% |
Drug Ineffective |
4.2% |
Hepatitis B |
4.2% |
Local Swelling |
4.2% |
Mucormycosis |
4.2% |
Orthostatic Hypotension |
4.2% |
Pneumocystis Jiroveci Pneumonia |
4.2% |
Pyrexia |
4.2% |
Rectal Haemorrhage |
4.2% |
Respiratory Failure |
4.2% |
Rhabdomyoma |
4.2% |
Skin Ulcer |
4.2% |
Tachycardia |
4.2% |
Throat Irritation |
4.2% |
|
Concomitant |
Rheumatoid Arthritis |
28.0% |
Drug Use For Unknown Indication |
23.5% |
Crohn's Disease |
6.1% |
Renal Transplant |
5.3% |
Diffuse Large B-cell Lymphoma |
4.2% |
Prophylaxis Against Gastrointestinal Ulcer |
3.4% |
Colitis Ulcerative |
3.0% |
Hypertension |
3.0% |
Product Used For Unknown Indication |
3.0% |
Acne |
2.3% |
Asthma |
2.3% |
Heart Transplant |
2.3% |
Pulmonary Hypertension |
2.3% |
Diabetes Mellitus |
1.9% |
Osteoporosis |
1.9% |
Hyperlipidaemia |
1.5% |
Infection |
1.5% |
Metastases To Bone |
1.5% |
Nasopharyngitis |
1.5% |
Thrombosis Prophylaxis |
1.5% |
|
Transient Ischaemic Attack |
9.1% |
Vomiting |
9.1% |
Weight Increased |
9.1% |
Oedema Peripheral |
6.8% |
Pyrexia |
6.8% |
Interstitial Lung Disease |
4.5% |
Nephropathy Toxic |
4.5% |
Pain In Extremity |
4.5% |
Rash Pustular |
4.5% |
Renal Cancer |
4.5% |
Renal Failure |
4.5% |
Respiratory Failure |
4.5% |
Upper Respiratory Tract Infection |
4.5% |
Urinary Tract Infection |
4.5% |
Vision Blurred |
4.5% |
Weight Decreased |
4.5% |
Anaphylactic Reaction |
2.3% |
Angioedema |
2.3% |
Aplasia Pure Red Cell |
2.3% |
Atrial Flutter |
2.3% |
|